Mitsubishi UFJ Trust & Banking Corp Has $2.77 Million Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA

Mitsubishi UFJ Trust & Banking Corp reduced its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 47.5% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 148,746 shares of the real estate investment trust’s stock after selling 134,842 shares during the period. Mitsubishi UFJ Trust & Banking Corp owned approximately 0.06% of Sabra Healthcare REIT worth $2,773,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in SBRA. VIRGINIA RETIREMENT SYSTEMS ET Al increased its holdings in shares of Sabra Healthcare REIT by 51.2% during the 3rd quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 577,800 shares of the real estate investment trust’s stock worth $10,770,000 after acquiring an additional 195,600 shares during the last quarter. Franklin Resources Inc. lifted its holdings in shares of Sabra Healthcare REIT by 27.4% during the second quarter. Franklin Resources Inc. now owns 503,499 shares of the real estate investment trust’s stock worth $9,285,000 after buying an additional 108,268 shares in the last quarter. Tred Avon Family Wealth LLC acquired a new stake in Sabra Healthcare REIT in the 3rd quarter worth about $979,000. Advisors Capital Management LLC raised its position in shares of Sabra Healthcare REIT by 0.6% in the second quarter. Advisors Capital Management LLC now owns 2,246,965 shares of the real estate investment trust’s stock valued at $41,434,000 after buying an additional 14,356 shares in the last quarter. Finally, Advisors Asset Management Inc. boosted its stake in shares of Sabra Healthcare REIT by 3.6% in the second quarter. Advisors Asset Management Inc. now owns 183,189 shares of the real estate investment trust’s stock valued at $3,378,000 after buying an additional 6,312 shares during the period. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Price Performance

Shares of NASDAQ SBRA opened at $18.73 on Friday. The company has a market capitalization of $4.67 billion, a PE ratio of 26.01, a P/E/G ratio of 1.28 and a beta of 0.67. The company has a quick ratio of 5.19, a current ratio of 5.19 and a debt-to-equity ratio of 0.92. Sabra Healthcare REIT, Inc. has a twelve month low of $15.60 and a twelve month high of $19.97. The firm has a fifty day simple moving average of $19.05 and a 200 day simple moving average of $18.70.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.01. Sabra Healthcare REIT had a return on equity of 6.38% and a net margin of 23.50%.The firm had revenue of $190.04 million during the quarter, compared to the consensus estimate of $193.44 million. During the same period last year, the business posted $0.37 EPS. The business’s revenue was up 6.7% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. On average, sell-side analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 28th. Stockholders of record on Monday, November 17th were paid a $0.30 dividend. The ex-dividend date was Monday, November 17th. This represents a $1.20 annualized dividend and a dividend yield of 6.4%. Sabra Healthcare REIT’s payout ratio is currently 166.67%.

Wall Street Analyst Weigh In

A number of equities analysts have commented on SBRA shares. UBS Group initiated coverage on Sabra Healthcare REIT in a research note on Tuesday, November 18th. They set a “neutral” rating and a $20.00 price objective on the stock. National Bankshares set a $22.00 target price on Sabra Healthcare REIT in a research report on Friday, October 17th. Wells Fargo & Company boosted their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 25th. Weiss Ratings restated a “buy (b)” rating on shares of Sabra Healthcare REIT in a report on Thursday, January 22nd. Finally, Truist Financial boosted their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “hold” rating in a report on Tuesday, January 20th. Four equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $21.11.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.